| dc.contributor.author | Lustig, Yaniv | |
| dc.contributor.author | Mendelson, Ella | |
| dc.contributor.author | Paran, Nir | |
| dc.contributor.author | et al. | |
| dc.date.accessioned | 2022-08-26T19:19:40Z | |
| dc.date.available | 2022-08-26T19:19:40Z | |
| dc.date.issued | 2016-06 | |
| dc.identifier.uri | https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2016.21.26.30269 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/2821 | |
| dc.description.abstract | Zika virus RNA presence in serum, whole-blood and urine samples from six Israeli travellers symptomatic for Zika virus disease was examined. Whole-blood samples were positive for as late as 2 months (58 days) post-symptom onset, longer than for urine (26 days) and serum (3 days). These findings suggest the utility of whole blood in Zika infection diagnosis. | en_US |
| dc.language | English | en_US |
| dc.subject | Zika Research Project | en_US |
| dc.subject | Zika Virus | en_US |
| dc.subject | Zika Virus Disease | en_US |
| dc.subject | RNA | en_US |
| dc.subject | Israel | en_US |
| dc.title | Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016 | en_US |
| eihealth.country | Others | en_US |
| eihealth.category | Epidemiology and epidemiological studies | en_US |
| eihealth.type | Research protocol information | en_US |
| eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
| dc.relation.ispartofjournal | Eurosurveilance. Europe's journal on infectious disease surveillance, epidemiology, prevention and control | en_US |
| dc.contributor.corporatename | Israel. Ministry of Health. Central Virology Laboratory | en_US |
| dc.contributor.corporatename | Israel. Tel-Aviv University. School of Public Health | en_US |
